BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Plegridy (peginterferon beta-1a) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Plegridy (peginterferon beta-1a)\, from C
 linicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT03958877-6981@assetmemo.bio
DTSTAMP:20261121T005650Z
DTSTART;VALUE=DATE:20270520
DTEND;VALUE=DATE:20270521
SUMMARY:Plegridy (peginterferon beta-1a): Phase 3 readout est. (NCT03958877
 )
DESCRIPTION:Plegridy (peginterferon beta-1a)\, phase 3\, Multiple Sclerosis
 .\nStudy: A Study to Evaluate the Safety\, Tolerability\, and Efficacy of 
 BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatmen
 t of Relapsing-Remitting Multiple Sclerosis\nEstimated primary completion:
  20 May 2027. This is a ClinicalTrials.gov estimate\, not a confirmed read
 out date\, and it can move.\nDrug page: https://assetmemo.bio/drug/peginte
 rferon-beta-1a#upcoming-events\nRegistry record: https://clinicaltrials.go
 v/study/NCT03958877
URL:https://assetmemo.bio/drug/peginterferon-beta-1a#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
